Free signup for more
- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
Content analysis
?Positive | ||
Negative | ||
Uncertain | ||
Constraining | ||
Legalese | ||
Litigous | ||
Readability |
H.S. sophomore Avg
|
New words:
Acid, admission, Amplification, AUD, autoimmune, Bacteremia, bad, BlueIron, bound, carryover, CCP, Communist, Concerted, consecutive, crime, deconsolidated, deprive, deprived, detriment, dishonest, division, drawdown, entice, expressly, felony, freestanding, guilty, gynecological, habit, HFCA, HFCAA, HIBOR, HKSAR, Inline, Insud, Interbank, irrevocable, judgement, Latin, lent, Libra, Library, Manhattan, moral, Northern, Nucleic, overhead, Overnight, parallel, pension, plea, Pty, residual, revolving, Senate, SMPTH, SOFR, staphyloxathin, steadily, tendered, text, turpitude, unavailable, unconsolidated, wholesale, Yale
Removed:
acute, Adapted, affinity, amounting, assay, begun, Bloomberg, buying, cable, cadaveric, caption, Chi, clerical, collect, combine, Composite, confirmation, COO, coordinated, economy, Engineering, escrow, falling, formulated, guaranteed, Harbor, Heung, inhibited, lessee, liaison, Lily, Ling, linked, machining, mBio, modifying, netting, PA, persist, piggyback, pigmentation, Ping, pose, precision, promised, reaching, released, removing, repaid, repayment, repeated, roughly, SD, Sheng, soft, strike, synergistically, systemic, Tecford, triplicate, twelfth, waived, wife, WT, Yu, Yun
Filing tables
Filing exhibits
- 20-F Annual report (foreign)
- 1.1 Second Amended and Restated Articles of Association, As Amended
- 2.3 Description of Securities Registered Under Section 12 of the Exchange Act of 1934, As Amended
- 4.47 Concerted Action Agreement Between Aptorum Therapeutics Limited and Peace Range Limited Dated December 30, 2021 Regarding to Mios Pharmaceuticals Limited
- 4.48 Concerted Action Agreement Between Aptorum Therapeutics Limited and Peace Range Limited Dated December 30, 2021 Regarding to Scipio Life Sciences Limited
- 8.1 List of Subsidiaries
- 12.1 Certification
- 12.2 Certification
- 13.1 Certification
- 15.1 Consent of Marcum Bernstein & Pinchuk LLP
- Download Excel data file
- View Excel data file
APM similar filings
Filing view
External links
Exhibit 8.1
Note: Both Mios Pharmaceuticals Limited (“Mios”) and Scipio Life Sciences Limited (“Scipio”) issued Class A and Class B ordinary shares to various parties; for each such entity, each Class A ordinary share is entitled to 1 vote and 1 share of economic interest of the respective company, while each Class B ordinary share is entitled to 10 votes and 0.001 share of economic interest of the respective company. As of the date of this annual report, we hold 97.93% economic interest and 36.17% voting power in Mios, and 97.93% economic interest and 35.06% voting power in Scipio.